Literature DB >> 2579895

Production of a T-cell hybrid producing a lymphokine stimulating eosinophil differentiation.

D J Warren, C J Sanderson.   

Abstract

Spleen cells from mice undergoing a parasite-induced eosinophilia were fused with an azaguanine-resistant subline of the thymoma BW5147. A stable T hybrid (NIMP-TH1) was isolated and selected by recloning repeatedly by limiting dilution. The hybrid nature of NIMP-TH1 was confirmed by its expression of both parental alleles of Thy-1 and by chromosome analysis (modal chromosome number 102). On stimulation with phorbol myristate acetate, this hybrid releases a soluble activity which acts as a stimulator of eosinophil differentiation in vitro. Addition of hybrid conditioned medium to bone marrow cultures results in a selective stimulation of eosinophil production with no detectable increase in neutrophil or macrophage differentiation. The lymphokines interleukin-2 (IL-2) and interferon (IFN) are undetectable in NIMP-TH1 conditioned media. Although at high concentrations NIMP-TH1 supernatants are able to support very low levels of DNA synthesis in an IL-3-dependent cell line, and IL-3 appears to support low levels of eosinophil differentiation, dose-response curves show that the factor produced by NIMP-TH1 can be clearly segregated from IL-3 by its marked specificity for cells belonging to the eosinophil lineage. The factor present in these supernatants has been provisionally termed eosinophil differentiation factor (EDF).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2579895      PMCID: PMC1453548     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  T lymphocyte tissue culture lines produced by cell hybridization.

Authors:  G J Hämmerling
Journal:  Eur J Immunol       Date:  1977-10       Impact factor: 5.532

2.  Formation of eosinophilic-like granulocytic colonies by mouse bone marrow cells in vitro.

Authors:  D Metcalf; J Parker; H M Chester; P W Kincade
Journal:  J Cell Physiol       Date:  1974-10       Impact factor: 6.384

3.  Eosinophil response to migrating Ascaris suum larvae in normal and congenitally thymus-less mice.

Authors:  K Nielsen; L Fogh; S Andersen
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-12

4.  Antibodies to major histocompatibility antigens produced by hybrid cell lines.

Authors:  G Galfre; S C Howe; C Milstein; G W Butcher; J C Howard
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

5.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

6.  Differentiation antigens on mouse eosinophils and neutrophils identified by monoclonal antibodies.

Authors:  A F Lopez; M Strath; C J Sanderson
Journal:  Br J Haematol       Date:  1984-07       Impact factor: 6.998

7.  Specific release of neutrophillic- and eosinophilic-stimulating factors from sensitized lymphocytes.

Authors:  F W Ruscetti; R H Cypess; P A Chervenick
Journal:  Blood       Date:  1976-05       Impact factor: 22.113

8.  Schistosoma mansoni infection in mice depleted of thymus-dependent lymphocytes. I. Eosinophilia and immunologic responses to a schistosomal egg preparation.

Authors:  D P Fine; R D Buchanan; D G Colley
Journal:  Am J Pathol       Date:  1973-05       Impact factor: 4.307

9.  Specific suppressive factors produced by hybridomas derived from the fusion of enriched suppressor T cells and a T lymphoma cell line.

Authors:  M Taniguchi; J F Miller
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

10.  Mechanism of eosinophilia. II. Role of the lymphocyte.

Authors:  A Basten; P B Beeson
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307

View more
  10 in total

1.  Genetic control of eosinophilia. Analysis of production and response to eosinophil-differentiating factor in strains of mice infected with Trichinella spiralis.

Authors:  D A Lammas; L A Mitchell; D Wakelin
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

2.  Eosinophil differentiation factor also has B-cell growth factor activity: proposed name interleukin 4.

Authors:  C J Sanderson; A O'Garra; D J Warren; G G Klaus
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

Review 3.  New properties and roles for eosinophils in disease: discussion paper.

Authors:  C J Spry
Journal:  J R Soc Med       Date:  1985-10       Impact factor: 5.344

4.  Interleukin 4 (B-cell growth factor II/eosinophil differentiation factor) is a mitogen and differentiation factor for preactivated murine B lymphocytes.

Authors:  A O'Garra; D J Warren; M Holman; A M Popham; C J Sanderson; G G Klaus
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

5.  Eosinophil-activating factor (EAF) production by a human cell line (ESH 98) stimulated with tumour necrosis factor.

Authors:  K J Thorne; B A Richardson; A E Butterworth; M Stanley
Journal:  Immunology       Date:  1988-03       Impact factor: 7.397

6.  T-cell hybridomas specific for self and foreign thyroglobulins.

Authors:  D C Rayner; P J Delves; D Warren; I M Roitt; B R Champion
Journal:  Immunology       Date:  1987-02       Impact factor: 7.397

Review 7.  Phenotypic changes in growth-arrested T cell hybrids: a possible avenue to produce functional T cell hybridoma.

Authors:  Koichi Kubota; Kazuya Iwabuchi
Journal:  Front Immunol       Date:  2014-05-19       Impact factor: 7.561

8.  Differential regulation of IgG1 and IgE synthesis by interleukin 4.

Authors:  C M Snapper; F D Finkelman; W E Paul
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

9.  Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures.

Authors:  C J Sanderson; D J Warren; M Strath
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

10.  Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells.

Authors:  A F Lopez; C G Begley; D J Williamson; D J Warren; M A Vadas; C J Sanderson
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.